معرفی
Muhammad U. Baig, MBBS serves as an Assistant Professor in the Hematology/Oncology Division within the Department of Pediatrics at Loma Linda University School of Medicine. His clinical and research focus centers on pediatric hematology-oncology with specialization in neuro-oncology, leukemia, and palliative care for children with cancer.
Dr. Baig's research interests span multiple critical areas in pediatric oncology including:
- Development and implementation of novel therapies for brain tumors, particularly diffuse intrinsic pontine glioma (DIPG)
- Management of treatment-related complications in pediatric cancer patients
- Improvement of supportive care practices in pediatric oncology intensive care units
- Long-term survivorship issues including cognitive and sleep disturbances
- Palliative care interventions for terminal pediatric cancer pain
His publication record demonstrates consistent research activity with publications spanning from 2018 through 2025, showing particular concentration in 2021-2022 and a 2025 publication indicating ongoing research productivity. The articles reflect a strong clinical-translational focus with emphasis on therapeutic interventions, quality improvement initiatives, and survivorship outcomes in pediatric neuro-oncology and leukemia.
Dr. Baig maintains an extensive portfolio of clinical research activities as evidenced by his participation in numerous Children's Oncology Group (COG) trials and other collaborative studies. He serves as Principal Investigator for institutional studies and as an investigator on over thirty clinical trials spanning various pediatric malignancies including leukemias, brain tumors, sarcomas, and lymphomas.
His research program includes significant involvement with the Pediatric Hematology-Oncology Division at Loma Linda University Children's Hospital where he contributes to both clinical care and research infrastructure development, including projects related to cerebrospinal fluid liquid biopsy for CNS tumor diagnosis and characterization.
